Decrease in serum levels of adiponectin and increase in 8-OHdG: A culprit for cognitive impairment in the elderly with type 2 diabetes.
Adiponectin and 8-Hydroxy-2'-deoxyguanosine (8-OHdG) are identified as important biomarkers in the pathogenesis process of type 2 diabetes mellitus (T2DM). Whether adiponectin and 8-OHdG regulates cognitive decline in the elderly T2DM patients has been poorly understood. The aim of this study was to evaluate adiponectin and 8-OHdG amongst elderly patients with T2DM and to determine the role of adiponectin and 8-OHdG in the cognitive impairment of the elderly patients with T2DM. 57 individuals were recruited and analyzed finally, including 26 cases of type 2 diabetes without cognitive impairment and 31 cases of type 2 diabetes with cognitive impairment. All of them were received an examination of diabetes scales and the recording of blood glucose at different times. A primary diagnosis of diabetes was in line with the diagnosis criteria set by the American Diabetes Association (ADA). Statistical significance was defined as a P-value of less than 0.05. The variables of sex, age, body mass index (BMI), hypertension, diabetes, metabolic syndrome, lacunar cerebral infarction, smoking and drinking between T2DM patients without cognitive impairment and with cognitive impairment in the variables had no difference according to univariate analysis exploring each variable separately (p&amp;amp;gt;0.05). A significant difference had been demonstrated in the serum levels of adiponectin and 8-OHdG and the scales of MMSE and MoCA (p&amp;amp;amp;lt;0.05). There is no correlation between glucose metabolic value and cognitive outcome of T2DM patients. Serum levels of adiponectin and 8-OHdG could act as biomarkers of cognitive impairment degree in the elderly T2DM patients. Serum levels of adiponectin and 8-OHdG could act as specific and sensitive bio-markers for the early diagnosis and treatment of cognitive impairment in elderly T2DM patients. Serum levels of adiponectin and 8-OHdG have a close relation to the neurological cognitive outcome of the elderly T2DM patients.